hVIVO plc (LON:HVO – Get Free Report)’s share price was down 6.8% during mid-day trading on Friday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares traded hands during trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Stock Up 2.1 %
The company’s 50-day moving average price is GBX 23.39 and its 200 day moving average price is GBX 26.71. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The stock has a market cap of £132.67 million, a PE ratio of 650.00 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Five stocks we like better than hVIVO
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Legacy Tech Companies Reemerging as AI Leaders
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Why is the Ex-Dividend Date Significant to Investors?
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
